Incentives and clinical governance: money following quality?
This paper attempts to define quality (particularly in terms of evidence-based health care) and considers the incentives available to bring about improvements in quality. It examines the contribution that economics, as a discipline, can make to the debate on clinical governance. It considers the nature and importance of clinical governance, measuring quality, objectives and behaviour in questions raised concerning objectives and individual and team behaviour.
Ferguson
B
B
Nuffield Institute for Health, University of Leeds, UK.
Lim
J N
JN
D019317:Evidence-Based Medicine; D006801:Humans; D007857:Leadership; D008485:Medical Audit; D009042:Motivation; D015279:Organizational Culture; D010348:Patient Care Team / Q000592:standards*; D011785:Quality Assurance, Health Care / Q000191:economics*; D012052:Reimbursement, Incentive; D013222:State Medicine / Q000592:standards; D006113:United Kingdom